vs
Astrana Health, Inc.（ASTH）とICF International, Inc.（ICFI）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $443.7M、ICF International, Inc.の約2.1倍）。ICF International, Inc.の純利益率が高く（3.9% vs 0.7%、差は3.2%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs -10.6%）。ICF International, Inc.の直近四半期フリーキャッシュフローが多い（$68.7M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs -5.3%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
ICFインターナショナルはバージニア州レストンに本社を置く米国の上場企業で、コンサルティングとテクノロジーサービスを主力事業とし、業界を問わず顧客のニーズに応じた専門的なソリューションを提供しています。
ASTH vs ICFI — 直接比較
損益計算書 — Q4 2025 vs Q4 2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $443.7M |
| 純利益 | $6.6M | $17.3M |
| 粗利率 | — | 35.7% |
| 営業利益率 | 1.9% | 6.5% |
| 純利益率 | 0.7% | 3.9% |
| 売上前年比 | 42.9% | -10.6% |
| 純利益前年比 | 184.4% | -29.5% |
| EPS（希薄化後） | $0.12 | $0.95 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $443.7M | ||
| Q3 25 | $956.0M | $465.4M | ||
| Q2 25 | $654.8M | $476.2M | ||
| Q1 25 | $620.4M | $487.6M | ||
| Q4 24 | $665.2M | $496.3M | ||
| Q3 24 | $478.7M | $517.0M | ||
| Q2 24 | $486.3M | $512.0M | ||
| Q1 24 | $404.4M | $494.4M |
| Q4 25 | $6.6M | $17.3M | ||
| Q3 25 | $373.0K | $23.8M | ||
| Q2 25 | $9.4M | $23.7M | ||
| Q1 25 | $6.7M | $26.9M | ||
| Q4 24 | $-7.8M | $24.6M | ||
| Q3 24 | $16.1M | $32.7M | ||
| Q2 24 | $19.2M | $25.6M | ||
| Q1 24 | $14.8M | $27.3M |
| Q4 25 | — | 35.7% | ||
| Q3 25 | — | 37.6% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 38.0% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.7% | ||
| Q1 24 | — | 37.2% |
| Q4 25 | 1.9% | 6.5% | ||
| Q3 25 | 2.0% | 8.3% | ||
| Q2 25 | 3.1% | 8.4% | ||
| Q1 25 | 3.3% | 7.9% | ||
| Q4 24 | 0.1% | 7.3% | ||
| Q3 24 | 5.9% | 8.9% | ||
| Q2 24 | 6.2% | 8.3% | ||
| Q1 24 | 7.5% | 8.3% |
| Q4 25 | 0.7% | 3.9% | ||
| Q3 25 | 0.0% | 5.1% | ||
| Q2 25 | 1.4% | 5.0% | ||
| Q1 25 | 1.1% | 5.5% | ||
| Q4 24 | -1.2% | 4.9% | ||
| Q3 24 | 3.4% | 6.3% | ||
| Q2 24 | 3.9% | 5.0% | ||
| Q1 24 | 3.7% | 5.5% |
| Q4 25 | $0.12 | $0.95 | ||
| Q3 25 | $0.01 | $1.28 | ||
| Q2 25 | $0.19 | $1.28 | ||
| Q1 25 | $0.14 | $1.44 | ||
| Q4 24 | $-0.14 | $1.29 | ||
| Q3 24 | $0.33 | $1.73 | ||
| Q2 24 | $0.40 | $1.36 | ||
| Q1 24 | $0.31 | $1.44 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $5.3M |
| 総負債低いほど良い | — | $401.4M |
| 株主資本純資産 | $779.3M | $1.0B |
| 総資産 | $2.2B | $2.1B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.39× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $5.3M | ||
| Q3 25 | $463.4M | $4.0M | ||
| Q2 25 | $342.1M | $7.0M | ||
| Q1 25 | $260.9M | $5.7M | ||
| Q4 24 | $290.8M | $5.0M | ||
| Q3 24 | $350.3M | $6.9M | ||
| Q2 24 | $327.7M | $4.1M | ||
| Q1 24 | $337.3M | $3.7M |
| Q4 25 | — | $401.4M | ||
| Q3 25 | — | $449.4M | ||
| Q2 25 | — | $462.3M | ||
| Q1 25 | — | $502.0M | ||
| Q4 24 | — | $411.7M | ||
| Q3 24 | — | $419.1M | ||
| Q2 24 | — | $433.9M | ||
| Q1 24 | — | $474.7M |
| Q4 25 | $779.3M | $1.0B | ||
| Q3 25 | $775.5M | $1.0B | ||
| Q2 25 | $765.5M | $1.0B | ||
| Q1 25 | $745.4M | $968.9M | ||
| Q4 24 | $712.7M | $982.5M | ||
| Q3 24 | $704.6M | $976.3M | ||
| Q2 24 | $678.9M | $943.3M | ||
| Q1 24 | $653.5M | $916.1M |
| Q4 25 | $2.2B | $2.1B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | $1.3B | $2.1B | ||
| Q4 24 | $1.4B | $2.1B | ||
| Q3 24 | $1.3B | $2.0B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.52× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.43× | ||
| Q2 24 | — | 0.46× | ||
| Q1 24 | — | 0.52× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $75.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $68.7M |
| FCFマージンFCF / 売上 | -0.6% | 15.5% |
| 設備投資強度設備投資 / 売上 | 0.3% | 1.6% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 4.37× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $120.2M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $75.6M | ||
| Q3 25 | $10.0M | $47.3M | ||
| Q2 25 | $90.9M | $52.0M | ||
| Q1 25 | $16.6M | $-33.0M | ||
| Q4 24 | $-10.9M | $95.4M | ||
| Q3 24 | $34.0M | $25.5M | ||
| Q2 24 | $23.2M | $60.6M | ||
| Q1 24 | $6.0M | $-10.0M |
| Q4 25 | $-6.0M | $68.7M | ||
| Q3 25 | $7.4M | $41.8M | ||
| Q2 25 | $89.5M | $46.2M | ||
| Q1 25 | $13.6M | $-36.5M | ||
| Q4 24 | $-13.5M | $89.5M | ||
| Q3 24 | $31.7M | $20.4M | ||
| Q2 24 | $20.4M | $55.5M | ||
| Q1 24 | $5.6M | $-15.2M |
| Q4 25 | -0.6% | 15.5% | ||
| Q3 25 | 0.8% | 9.0% | ||
| Q2 25 | 13.7% | 9.7% | ||
| Q1 25 | 2.2% | -7.5% | ||
| Q4 24 | -2.0% | 18.0% | ||
| Q3 24 | 6.6% | 3.9% | ||
| Q2 24 | 4.2% | 10.8% | ||
| Q1 24 | 1.4% | -3.1% |
| Q4 25 | 0.3% | 1.6% | ||
| Q3 25 | 0.3% | 1.2% | ||
| Q2 25 | 0.2% | 1.2% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.4% | 1.2% | ||
| Q3 24 | 0.5% | 1.0% | ||
| Q2 24 | 0.6% | 1.0% | ||
| Q1 24 | 0.1% | 1.1% |
| Q4 25 | -0.44× | 4.37× | ||
| Q3 25 | 26.69× | 1.99× | ||
| Q2 25 | 9.65× | 2.20× | ||
| Q1 25 | 2.48× | -1.23× | ||
| Q4 24 | — | 3.88× | ||
| Q3 24 | 2.11× | 0.78× | ||
| Q2 24 | 1.21× | 2.37× | ||
| Q1 24 | 0.40× | -0.37× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
ICFI
| US Federal Government | $166.7M | 38% |
| Commercial | $164.4M | 37% |
| US State And Local Government | $78.7M | 18% |
| International Government | $33.8M | 8% |
